1-2 of 2
Ahmed Salem
Close
Sort by
Journal Articles

Impact of Polymorphisms in Pharmacokinetic Genes on Tyrosine Kinase Inhibitor (TKI) Tolerability in Patients with Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Jai N Patel, Karine Eboli Lopes, Lawrence J Druhan, Hang Zeng, Travis Beam, Donald C Moore, Ahmed Salem, Issam Hamadeh, Quanisha Savage, Aleksander L. Chojecki, Jing Ai, Thomas G. Knight, Brittany Knick Ragon, Nilay A. Shah, Srinivasa Reddy Sanikommu, Nury M Steuerwald, Mathew Smith, Alicia Hamilton, Keerthana Rangavajhula, Ariel Bell, Kendra Drummond, James T. Symanowski, Michael R. Grunwald
Journal: Blood
Blood (2022) 140 (Supplement 1): 11530–11531.
https://doi.org/10.1182/blood-2022-166277
Published: 2022
Journal Articles

A Phase 2 Study of ABT-199 (GDC-0199) in Patients with Acute Myelogenous Leukemia (AML)

Marina Konopleva, MD PhD, Daniel A. Pollyea, MD MS, Jalaja Potluri, MD, Brenda J. Chyla, PhD, Todd Busman, MS, Evelyn McKeegan, PhD, Ahmed Salem, PhD, Ming Zhu, PhD, Justin L. Ricker, MD PhD, William Blum, MD, Courtney D. DiNardo, MD, Martin Dunbar, DRPH, Rachel Kirby, Nancy Falotico, Joel D. Leverson, PhD, Rod A. Humerickhouse, MD PhD, Mack Mabry, MD, Richard M. Stone, MD, Hagop M. Kantarjian, MD, Anthony G. Letai, MD PhD
Journal: Blood
Blood (2014) 124 (21): 118.
https://doi.org/10.1182/blood.V124.21.118.118
Published: 2014